(Q47987130)

English

One-year treatment with ethyl esters of n-3 fatty acids in patients with hypertriglyceridemia and glucose intolerance: reduced triglyceridemia, total cholesterol and increased HDL-C without glycemic alterations.

scientific article published in April 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9622285

One-year treatment with ethyl esters of n-3 fatty acids in patients with hypertriglyceridemia and glucose intolerance: reduced triglyceridemia, total cholesterol and increased HDL-C without glycemic alterations. (English)

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9622285

hypertriglyceridemia

1 reference

based on heuristic

inferred from title

glucose intolerance

1 reference

based on heuristic

inferred from title

author name string

Sirtori CR

1

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9622285

Crepaldi G

2

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9622285

Manzato E

3

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9622285

Mancini M

4

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9622285

Rivellese A

5

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9622285

Paoletti R

6

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9622285

Pazzucconi F

7

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9622285

Pamparana F

8

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9622285

Stragliotto E

9

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9622285

publication date

1 April 1998

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9622285

Atherosclerosis

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9622285

137

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9622285

2

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9622285

419-427

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9622285

Cardiovascular Effects of n-3 Fatty Acids

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900298-0

7 January 2021

The inverse relation between fish consumption and 20-year mortality from coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900298-0

7 January 2021

Long-term effects of dietary marine omega-3 fatty acids upon plasma and cellular lipids, platelet function, and eicosanoid formation in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900298-0

7 January 2021

Fatty fish-induced changes in membrane lipid composition and viscosity of human erythrocyte suspensions

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900298-0

7 January 2021

Effects of n-3 fatty acids and fenofibrate on lipid and hemorrheological parameters in familial dysbetalipoproteinemia and familial hypertriglyceridemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900298-0

7 January 2021

n-3 polyunsaturated fatty acids: update 1995.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900298-0

7 January 2021

Fish oil improves arterial compliance in non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900298-0

7 January 2021

Adverse metabolic effect of omega-3 fatty acids in non-insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900298-0

7 January 2021

Effects of omega-3 fish oils on lipid metabolism, glycemic control, and blood pressure in type II diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900298-0

7 January 2021

Dose-response effects of dietary marine oil on carbohydrate and lipid metabolism in normal subjects and patients with hypertriglyceridemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900298-0

7 January 2021

Elevated plasma glucose and lowered triglyceride levels from omega-3 fatty acid supplementation in type II diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900298-0

7 January 2021

Dietary fish oil and insulin action in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900298-0

7 January 2021

A controlled study on the effects of n-3 fatty acids on lipid and glucose metabolism in non-insulin-dependent diabetic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900298-0

7 January 2021

Effects of low-dose EPA-E on glycemic control, lipid profile, lipoprotein(a), platelet aggregation, viscosity, and platelet and vessel wall interaction in NIDDM

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900298-0

7 January 2021

Effects of n-3 polyunsaturated fatty acids on glucose homeostasis and blood pressure in essential hypertension. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900298-0

7 January 2021

N-3 fatty acids do not lead to an increased diabetic risk in patients with hyperlipidemia and abnormal glucose tolerance. Italian Fish Oil Multicenter Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900298-0

7 January 2021

Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900298-0

7 January 2021

Changes of n-3 and n-6 fatty acids in plasma and circulating cells of normal subjects, after prolonged administration of 20:5 (EPA) and 22:6 (DHA) ethyl esters and prolonged washout.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900298-0

7 January 2021

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900298-0

7 January 2021

Effects of fibrates on serum lipids and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900298-0

7 January 2021

Fraudulent (and non fraudulent) fatty acids for human health

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900298-0

7 January 2021

Heterogeneity of low density lipoprotein responses to fish-oil supplementation in hypertriglyceridemic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900298-0

7 January 2021

Dietary fish oil decreases low-density-lipoprotein clearance in nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900298-0

7 January 2021

Blood pressure and atherogenic lipoprotein profiles of fish-diet and vegetarian villagers in Tanzania: the Lugalawa study

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900298-0

7 January 2021

Improvement of serum lipids and blood pressure during intervention with n-3 fatty acids was not associated with changes in insulin levels in subjects with combined hyperlipidaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900298-0

7 January 2021

Comparison of effects of N-3 to N-6 fatty acids on serum level of lipoprotein(a) in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900298-0

7 January 2021

Long-term effects of n-3 fatty acids on serum lipids and glycaemic control.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900298-0

7 January 2021

Olive oil, corn oil, and n-3 fatty acids differently affect lipids, lipoproteins, platelets, and superoxide formation in type II hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900298-0

7 January 2021

Treatment with omega-3 fatty acid ethyl esters in hyperlipoproteinaemias: comparative studies on lipid metabolism and thrombotic indexes.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900298-0

7 January 2021

Lipoprotein lipases, lipoprotein density gradient profile and LDL receptor activity in miniature pigs fed fish oil and corn oil.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900298-0

7 January 2021

Lipoprotein abnormalities in well-treated type II diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900298-0

7 January 2021

Docosahexaenoic and eicosapentaenoic acids in plasma phospholipids are divergently associated with high density lipoprotein in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900298-0

7 January 2021

LDL subclass phenotypes and the insulin resistance syndrome in women.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2897%2900298-0

7 January 2021

Identifiers

10.1016/S0021-9150(97)00298-0

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9622285

1 reference

Europe PubMed Central

7 February 2018

http://europepmc.org/abstract/MED/9622285

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47987130&oldid=1527541686"